According to our (Global Info Research) latest study, the global Intracranial Pressure Monitoring Device market size was valued at US$ 626 million in 2025 and is forecast to a readjusted size of US$ 911 million by 2032 with a CAGR of 5.4% during review period.
An intracranial pressure (ICP) monitoring device is a neurocritical-care system intended for short-term, continuous monitoring and recording of intracranial pressure and its trends. It typically combines an in-body sensor/catheter or probe, a pressure transduction and signal-conditioning chain, bedside display/alarms, interconnects, and software to provide actionable, auditable pressure information in high-risk settings such as severe brain injury, subarachnoid hemorrhage, and hydrocephalus.In 2025, global Intracranial Pressure Monitoring Device production reached approximately 55.32 K Units and price is about 11 K USD/Unit.The average gross profit margin of this product is 48%.
Rising demand for earlier risk detection and protocolized neurocritical management is elevating ICP from a single value to a trend-based control variable embedded in standardized care pathways. Clinical guidance has long articulated the role of ICP monitoring in severe traumatic brain injury, supporting broader adoption where it improves decision consistency and resource allocation. At the same time, ICU workflow needs are accelerating innovation toward systems that are easier to deploy, safer to manage, and more compatible with broader multimodal monitoring ecosystems. The Brain Trauma Foundation guidelines provide explicit indications that help formalize clinical adoption and training. Constraints center on invasiveness, measurement reliability, and evidence consistency. Invasive placement introduces practical barriers such as infection/bleeding risk and higher nursing burden; sensor drift, zeroing practices, and system consistency can directly influence treatment decisions, making robust calibration and quality control essential. Adoption can also vary across institutions due to differences in how monitoring is linked to intervention protocols and outcome tracking. Regulatory recall history tied to packaging/sterilization effects underscores that supply-chain and process control are critical to long-term trust in a high-stakes monitoring category. Demand is shifting from “ICP alone” to integrated neurocritical monitoring: providers increasingly want ICP linked with perfusion, oxygenation, metabolic, and imaging signals to create an interpretable risk picture, supported by smarter alarms and standardized documentation to reduce manual errors. Noninvasive ICP approaches are gaining attention for triage, transport, and resource-limited settings, typically positioned as complementary screening/trending tools rather than replacements for invasive reference methods. Growing emphasis on patient-specific thresholds, pediatric and postoperative pathways, and longitudinal real-world datasets is also pushing competition from hardware features toward protocol-driven delivery and data-enabled service models. The upstream stack is defined by biocompatible materials, precision sensing, and sterile manufacturing. Invasive probes/catheters commonly use medical-grade polymers and metals in composite structures, integrating miniature pressure sensing (e.g., piezoresistive MEMS or fiber-optic approaches), signal conditioning, and shielded connectors designed to remain stable in physiologic environments with minimal drift. Bedside monitors add analog/digital electronics, isolation power design, software algorithms, and connectivity. Sterile packaging, batch consistency, traceable identification, and validated calibration methods are decisive supply-chain nodes for short-term continuous monitoring devices. U.S. Food and Drug Administration provides the regulatory definition and classification for ICP monitoring devices and recognizes consensus standards that set expectations for labeling, safety, and performance—raising the engineering and quality threshold for market entrants.
This report is a detailed and comprehensive analysis for global Intracranial Pressure Monitoring Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Intracranial Pressure Monitoring Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Intracranial Pressure Monitoring Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Intracranial Pressure Monitoring Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K US$/Unit), 2021-2032
Global Intracranial Pressure Monitoring Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intracranial Pressure Monitoring Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intracranial Pressure Monitoring Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Integra LifeSciences, Medtronic, Johnson & Johnson, Sophysa, Raumedic, Spiegelberg, HaiWeiKang, HeadSense Medical, Vittamed, Comen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Intracranial Pressure Monitoring Device market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Invasive Intracranial Pressure Monitoring Device
Noninvasive Intracranial Pressure Monitoring Device
Market segment by Placement
Intraventricular
Intraparenchymal Probe
Subdural
Other
Market segment by Disease Type
Traumatic Brain Injury
Intracerebral Hemorrhage
Meningitis
Subarachnoid Hemorrhage
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Integra LifeSciences
Medtronic
Johnson & Johnson
Sophysa
Raumedic
Spiegelberg
HaiWeiKang
HeadSense Medical
Vittamed
Comen
PrimaNova
TALEND MEDICAL
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intracranial Pressure Monitoring Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intracranial Pressure Monitoring Device, with price, sales quantity, revenue, and global market share of Intracranial Pressure Monitoring Device from 2021 to 2026.
Chapter 3, the Intracranial Pressure Monitoring Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intracranial Pressure Monitoring Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Intracranial Pressure Monitoring Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intracranial Pressure Monitoring Device.
Chapter 14 and 15, to describe Intracranial Pressure Monitoring Device sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Intracranial Pressure Monitoring Device. Industry analysis & Market Report on Intracranial Pressure Monitoring Device is a syndicated market report, published as Global Intracranial Pressure Monitoring Device Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Intracranial Pressure Monitoring Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.